71.67 USD
-0.75 (-1.04%)
71.67 USD
0 (0%)
Overall HALO gets a fundamental rating of 7 out of 10. We evaluated HALO against 528 industry peers in the Biotechnology industry. While HALO has a great profitability rating, there are some minor concerns on its financial health. An interesting combination arises when we look at growth and value: HALO is growing strongly while it also seems undervalued. These ratings would make HALO suitable for value and growth investing!
1. Profitability
1.1 Basic Checks
- In the past year HALO was profitable.
- HALO had a positive operating cash flow in the past year.
- HALO had positive earnings in each of the past 5 years.
- HALO had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- HALO has a Return On Assets of 26.81%. This is amongst the best in the industry. HALO outperforms 97.73% of its industry peers.
- HALO's Return On Equity of 118.17% is amongst the best of the industry. HALO outperforms 99.62% of its industry peers.
- The Return On Invested Capital of HALO (42.77%) is better than 99.24% of its industry peers.
- HALO had an Average Return On Invested Capital over the past 3 years of 17.81%. This is in line with the industry average of 18.28%.
- The last Return On Invested Capital (42.77%) for HALO is above the 3 year average (17.81%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.81% | ||
| ROE | 118.17% | ||
| ROIC | 42.77% |
ROA(3y)16.25%
ROA(5y)21.49%
ROE(3y)192.36%
ROE(5y)173.4%
ROIC(3y)17.81%
ROIC(5y)29.79%
1.3 Margins
- HALO's Profit Margin of 47.91% is amongst the best of the industry. HALO outperforms 98.11% of its industry peers.
- HALO's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 59.33%, HALO belongs to the top of the industry, outperforming 99.81% of the companies in the same industry.
- In the last couple of years the Operating Margin of HALO has declined.
- Looking at the Gross Margin, with a value of 84.55%, HALO belongs to the top of the industry, outperforming 87.12% of the companies in the same industry.
- HALO's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 59.33% | ||
| PM (TTM) | 47.91% | ||
| GM | 84.55% |
OM growth 3Y-4.44%
OM growth 5YN/A
PM growth 3Y-21.62%
PM growth 5YN/A
GM growth 3Y1.07%
GM growth 5Y1.9%
2. Health
2.1 Basic Checks
- HALO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- HALO has less shares outstanding than it did 1 year ago.
- HALO has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for HALO has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 5.18 indicates that HALO is not in any danger for bankruptcy at the moment.
- HALO has a better Altman-Z score (5.18) than 72.92% of its industry peers.
- HALO has a debt to FCF ratio of 2.51. This is a good value and a sign of high solvency as HALO would need 2.51 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 2.51, HALO belongs to the best of the industry, outperforming 93.37% of the companies in the same industry.
- HALO has a Debt/Equity ratio of 1.59. This is a high value indicating a heavy dependency on external financing.
- HALO has a Debt to Equity ratio of 1.59. This is in the lower half of the industry: HALO underperforms 76.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.59 | ||
| Debt/FCF | 2.51 | ||
| Altman-Z | 5.18 |
ROIC/WACC5.39
WACC7.94%
2.3 Liquidity
- A Current Ratio of 1.59 indicates that HALO should not have too much problems paying its short term obligations.
- HALO has a Current ratio of 1.59. This is in the lower half of the industry: HALO underperforms 79.92% of its industry peers.
- A Quick Ratio of 1.37 indicates that HALO should not have too much problems paying its short term obligations.
- HALO has a worse Quick ratio (1.37) than 81.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
- HALO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.55%, which is quite impressive.
- The Earnings Per Share has been growing by 30.12% on average over the past years. This is a very strong growth
- HALO shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.19%.
- HALO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.95% yearly.
EPS 1Y (TTM)48.55%
EPS 3Y30.12%
EPS 5YN/A
EPS Q2Q%35.43%
Revenue 1Y (TTM)31.19%
Revenue growth 3Y31.82%
Revenue growth 5Y38.95%
Sales Q2Q%22.12%
3.2 Future
- The Earnings Per Share is expected to grow by 17.78% on average over the next years. This is quite good.
- The Revenue is expected to grow by 13.23% on average over the next years. This is quite good.
EPS Next Y51.29%
EPS Next 2Y40.02%
EPS Next 3Y32.08%
EPS Next 5Y17.78%
Revenue Next Year33.82%
Revenue Next 2Y29.25%
Revenue Next 3Y23.48%
Revenue Next 5Y13.23%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- HALO is valuated correctly with a Price/Earnings ratio of 12.73.
- Based on the Price/Earnings ratio, HALO is valued cheaper than 96.97% of the companies in the same industry.
- HALO's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.30.
- The Price/Forward Earnings ratio is 8.64, which indicates a very decent valuation of HALO.
- Based on the Price/Forward Earnings ratio, HALO is valued cheaper than 98.86% of the companies in the same industry.
- HALO is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.73 | ||
| Fwd PE | 8.64 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, HALO is valued cheaper than 96.59% of the companies in the same industry.
- HALO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HALO is cheaper than 96.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.99 | ||
| EV/EBITDA | 10.93 |
4.3 Compensation for Growth
- HALO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- HALO has an outstanding profitability rating, which may justify a higher PE ratio.
- HALO's earnings are expected to grow with 32.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y40.02%
EPS Next 3Y32.08%
5. Dividend
5.1 Amount
- No dividends for HALO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
71.67
-0.75 (-1.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)N/A N/A
Inst Owners105.85%
Inst Owner Change0.92%
Ins Owners0.81%
Ins Owner Change-0.62%
Market Cap8.43B
Revenue(TTM)1.24B
Net Income(TTM)595.49M
Analysts76
Price Target77.52 (8.16%)
Short Float %10.75%
Short Ratio5.57
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.41%
Min EPS beat(2)3.56%
Max EPS beat(2)19.26%
EPS beat(4)4
Avg EPS beat(4)11.06%
Min EPS beat(4)3.56%
Max EPS beat(4)19.26%
EPS beat(8)7
Avg EPS beat(8)12.2%
EPS beat(12)10
Avg EPS beat(12)9.54%
EPS beat(16)13
Avg EPS beat(16)9.68%
Revenue beat(2)2
Avg Revenue beat(2)6.93%
Min Revenue beat(2)2.18%
Max Revenue beat(2)11.69%
Revenue beat(4)4
Avg Revenue beat(4)7.01%
Min Revenue beat(4)1.36%
Max Revenue beat(4)12.81%
Revenue beat(8)6
Avg Revenue beat(8)5.71%
Revenue beat(12)7
Avg Revenue beat(12)2.94%
Revenue beat(16)9
Avg Revenue beat(16)2.47%
PT rev (1m)0%
PT rev (3m)1.84%
EPS NQ rev (1m)-0.31%
EPS NQ rev (3m)1.25%
EPS NY rev (1m)0%
EPS NY rev (3m)1.77%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.71%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.73 | ||
| Fwd PE | 8.64 | ||
| P/S | 6.78 | ||
| P/FCF | 13.99 | ||
| P/OCF | 13.79 | ||
| P/B | 16.73 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.93 |
EPS(TTM)5.63
EY7.86%
EPS(NY)8.29
Fwd EY11.57%
FCF(TTM)5.12
FCFY7.15%
OCF(TTM)5.2
OCFY7.25%
SpS10.57
BVpS4.28
TBVpS-2.22
PEG (NY)0.25
PEG (5Y)N/A
Graham Number23.3
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.81% | ||
| ROE | 118.17% | ||
| ROCE | 53.28% | ||
| ROIC | 42.77% | ||
| ROICexc | 86.79% | ||
| ROICexgc | N/A | ||
| OM | 59.33% | ||
| PM (TTM) | 47.91% | ||
| GM | 84.55% | ||
| FCFM | 48.47% |
ROA(3y)16.25%
ROA(5y)21.49%
ROE(3y)192.36%
ROE(5y)173.4%
ROIC(3y)17.81%
ROIC(5y)29.79%
ROICexc(3y)23.94%
ROICexc(5y)N/A
ROICexgc(3y)71.73%
ROICexgc(5y)N/A
ROCE(3y)22.19%
ROCE(5y)37.11%
ROICexgc growth 3Y-1.13%
ROICexgc growth 5YN/A
ROICexc growth 3Y-28.16%
ROICexc growth 5YN/A
OM growth 3Y-4.44%
OM growth 5YN/A
PM growth 3Y-21.62%
PM growth 5YN/A
GM growth 3Y1.07%
GM growth 5Y1.9%
F-Score8
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.59 | ||
| Debt/FCF | 2.51 | ||
| Debt/EBITDA | 0.98 | ||
| Cap/Depr | 10.51% | ||
| Cap/Sales | 0.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.59% | ||
| Profit Quality | 101.16% | ||
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 5.18 |
F-Score8
WACC7.94%
ROIC/WACC5.39
Cap/Depr(3y)13.62%
Cap/Depr(5y)33.32%
Cap/Sales(3y)1.21%
Cap/Sales(5y)0.98%
Profit Quality(3y)118.15%
Profit Quality(5y)93.9%
High Growth Momentum
Growth
EPS 1Y (TTM)48.55%
EPS 3Y30.12%
EPS 5YN/A
EPS Q2Q%35.43%
EPS Next Y51.29%
EPS Next 2Y40.02%
EPS Next 3Y32.08%
EPS Next 5Y17.78%
Revenue 1Y (TTM)31.19%
Revenue growth 3Y31.82%
Revenue growth 5Y38.95%
Sales Q2Q%22.12%
Revenue Next Year33.82%
Revenue Next 2Y29.25%
Revenue Next 3Y23.48%
Revenue Next 5Y13.23%
EBIT growth 1Y54.59%
EBIT growth 3Y25.97%
EBIT growth 5YN/A
EBIT Next Year61.82%
EBIT Next 3Y38.25%
EBIT Next 5Y15.57%
FCF growth 1Y70.36%
FCF growth 3Y16.28%
FCF growth 5YN/A
OCF growth 1Y65.76%
OCF growth 3Y16.96%
OCF growth 5YN/A
HALOZYME THERAPEUTICS INC / HALO FAQ
Can you provide the ChartMill fundamental rating for HALOZYME THERAPEUTICS INC?
ChartMill assigns a fundamental rating of 7 / 10 to HALO.
Can you provide the valuation status for HALOZYME THERAPEUTICS INC?
ChartMill assigns a valuation rating of 9 / 10 to HALOZYME THERAPEUTICS INC (HALO). This can be considered as Undervalued.
Can you provide the profitability details for HALOZYME THERAPEUTICS INC?
HALOZYME THERAPEUTICS INC (HALO) has a profitability rating of 8 / 10.
What is the financial health of HALOZYME THERAPEUTICS INC (HALO) stock?
The financial health rating of HALOZYME THERAPEUTICS INC (HALO) is 6 / 10.
Can you provide the expected EPS growth for HALO stock?
The Earnings per Share (EPS) of HALOZYME THERAPEUTICS INC (HALO) is expected to grow by 51.29% in the next year.